Wednesday, March 27, 2019 1:06:05 AM
$54.99 Sale price$1.00 Save $53.99
https://earthsciencetech.com/collections/frontpage/products/new-1-2-ounce-high-grade-full-spectrum-cannabinoids-orange-blossom-328-5mg-v4
ETST’s High Grade Full Spectrum Cannabinoid Orange Blossom is composed of Unfiltered Industrial Full Spectrum Hemp Oil mixed and formulated with Essential Orange Oil, Orange Blossom Honey, Coconut MCT oil, and Vitamin E.
Our High Grade Full Spectrum Cannabinoid oils all contain Unfiltered Industrial Full Spectrum Hemp oil and Coconut MCT oil enhancing delivery and maximizing absorption.
Our High Grade Full Spectrum Cannabinoids are derived from Industrial Hemp plants with a high cannabinoid content. The Hemp used is extracted using Super-critical CO2 extraction to ensure highest quality of cannabinoids maintaining all naturally occurring therapeutic properties intact.
The High-Grade Hemp Cannabinoids we use are full spectrum extract, not synthetic nor an isolate. It contains a variety of valuable phyto-nutrients, synergistic cannabinoids, essential oils and other compounds found in the industrial hemp plant.
Product Contents And Testing
Cannabinoids per serving: 21.90mg
CBD: 16.67mg
CBDV: 0.11mg
CBG: 0.34mg
CBC: 1.05mg
CBN: 0.04mg
CBDa: 3.60mg
CBGa: 0.09mg
Ingredients: Coconut MCT Oil, Unfiltered Industrial Full Spectrum Hemp Oil, Orange Blossom Honey, Essential Orange Oil, and Vitamin E.
Recent ETST News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 08:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 12:52:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:20:11 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/27/2024 01:30:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:05:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 02:05:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 05:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:59:37 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 11:10:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 11:01:45 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 12:50:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2023 11:08:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 04:51:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 11:16:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 01:01:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 03:41:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/28/2023 01:10:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/27/2023 08:53:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM